Literature DB >> 24297188

Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study.

Thomas A Dewland, Eric Vittinghoff, Mala C Mandyam, Susan R Heckbert, David S Siscovick, Phyllis K Stein, Bruce M Psaty, Nona Sotoodehnia, John S Gottdiener, Gregory M Marcus.   

Abstract

BACKGROUND: Atrial fibrillation (AF) prediction models have unclear clinical utility given the absence of AF prevention therapies and the immutability of many risk factors. Premature atrial contractions (PACs) play a critical role in AF pathogenesis and may be modifiable.
OBJECTIVE: To investigate whether PAC count improves model performance for AF risk.
DESIGN: Prospective cohort study.
SETTING: 4 U.S. communities. PATIENTS: A random subset of 1260 adults without prevalent AF enrolled in the Cardiovascular Health Study between 1989 and 1990. MEASUREMENTS: The PAC count was quantified by 24-hour electrocardiography. Participants were followed for the diagnosis of incident AF or death. The Framingham AF risk algorithm was used as the comparator prediction model.
RESULTS: In adjusted analyses, doubling the hourly PAC count was associated with a significant increase in AF risk (hazard ratio, 1.17 [95% CI, 1.13 to 1.22]; P < 0.001) and overall mortality (hazard ratio, 1.06 [CI, 1.03 to 1.09]; P < 0.001). Compared with the Framingham model, PAC count alone resulted in similar AF risk discrimination at 5 and 10 years of follow-up and superior risk discrimination at 15 years. The addition of PAC count to the Framingham model resulted in significant 10-year AF risk discrimination improvement (c-statistic, 0.65 vs. 0.72; P < 0.001), net reclassification improvement (23.2% [CI, 12.8% to 33.6%]; P < 0.001), and integrated discrimination improvement (5.6% [CI, 4.2% to 7.0%]; P < 0.001). The specificity for predicting AF at 15 years exceeded 90% for PAC counts more than 32 beats/h. LIMITATION: This study does not establish a causal link between PACs and AF.
CONCLUSION: The addition of PAC count to a validated AF risk algorithm provides superior AF risk discrimination and significantly improves risk reclassification. Further study is needed to determine whether PAC modification can prospectively reduce AF risk. PRIMARY FUNDING SOURCE: American Heart Association, Joseph Drown Foundation, and National Institutes of Health.

Entities:  

Mesh:

Year:  2013        PMID: 24297188      PMCID: PMC4115459          DOI: 10.7326/0003-4819-159-11-201312030-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

1.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

2.  Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.

Authors:  Boon-Hor Chong; Vincent Pong; Kwok-Fai Lam; Shasha Liu; Ming-Liang Zuo; Yuk-Fai Lau; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal:  Europace       Date:  2011-12-19       Impact factor: 5.214

3.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study.

Authors:  D G Ives; A L Fitzpatrick; D E Bild; B M Psaty; L H Kuller; P M Crowley; R G Cruise; S Theroux
Journal:  Ann Epidemiol       Date:  1995-07       Impact factor: 3.797

4.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

5.  Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system.

Authors:  C Kolb; S Nürnberger; G Ndrepepa; B Zrenner; A Schömig; C Schmitt
Journal:  Am J Cardiol       Date:  2001-10-15       Impact factor: 2.778

6.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

7.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

Authors:  G S Tell; L P Fried; B Hermanson; T A Manolio; A B Newman; N O Borhani
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

8.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

9.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study.

Authors:  B M Psaty; L H Kuller; D Bild; G L Burke; S J Kittner; M Mittelmark; T R Price; P M Rautaharju; J Robbins
Journal:  Ann Epidemiol       Date:  1995-07       Impact factor: 3.797

10.  Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy.

Authors:  Dieter Wallmann; David Tüller; Kerstin Wustmann; Pascal Meier; Jörg Isenegger; Marcel Arnold; Heinrich P Mattle; Etienne Delacrétaz
Journal:  Stroke       Date:  2007-06-21       Impact factor: 7.914

View more
  67 in total

1.  Structural contributions to fibrillatory rotors in a patient-derived computational model of the atria.

Authors:  Matthew J Gonzales; Kevin P Vincent; Wouter-Jan Rappel; Sanjiv M Narayan; Andrew D McCulloch
Journal:  Europace       Date:  2014-11       Impact factor: 5.214

2.  Inflammation, Inflammasome Activation, and Atrial Fibrillation.

Authors:  David R Van Wagoner; Mina K Chung
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

Review 3.  Cardioembolic Stroke.

Authors:  Hooman Kamel; Jeff S Healey
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

4.  Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study).

Authors:  Wesley T O'Neal; Hooman Kamel; Suzanne E Judd; Monika M Safford; Viola Vaccarino; Virginia J Howard; George Howard; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2017-06-15       Impact factor: 2.778

5.  Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey).

Authors:  Waqas Qureshi; Amit J Shah; Taufiq Salahuddin; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2014-04-16       Impact factor: 2.778

Review 6.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

7.  Premature Atrial Contractions on the Screening Electrocardiogram and Risk of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Wesley T O'Neal; Hooman Kamel; Dawn Kleindorfer; Suzanne E Judd; George Howard; Virginia J Howard; Elsayed Z Soliman
Journal:  Neuroepidemiology       Date:  2016-08-17       Impact factor: 3.282

8.  Electrocardiographic Predictors of Incident Atrial Fibrillation.

Authors:  Kaylin T Nguyen; Eric Vittinghoff; Thomas A Dewland; Mala C Mandyam; Phyllis K Stein; Elsayed Z Soliman; Susan R Heckbert; Gregory M Marcus
Journal:  Am J Cardiol       Date:  2016-06-14       Impact factor: 2.778

9.  Ectopy and expectations: can we predict atrial fibrillation, and should we try?

Authors:  Daniel B Kramer; Peter J Zimetbaum
Journal:  Ann Intern Med       Date:  2013-12-03       Impact factor: 25.391

10.  Atrial ectopy as a mediator of the association between race and atrial fibrillation.

Authors:  Matthew A Christensen; Kaylin T Nguyen; Phyllis K Stein; Raymond B Fohtung; Elsayed Z Soliman; Thomas A Dewland; Eric Vittinghoff; Bruce M Psaty; Susan R Heckbert; Gregory M Marcus
Journal:  Heart Rhythm       Date:  2017-10-27       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.